13F

MGNX MACROGENICS INC

2026Q1 · CUSIP 556099109 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
108
Δ holders QoQ
+20
Breadth percentile
Top 16%
Whale holders
59
Δ whales
+7
Inst. holding value
$125M
New positions
32
Closed positions
12
Price momentum (1Q)
Put / Call
2/3

Breadth history (34 quarters)

2018Q1: Δ+14 · h=133 2018Q2: Δ-7 · h=126 2018Q3: Δ+5 · h=131 2018Q4: Δ+3 · h=134 2019Q1: Δ+24 · h=158 2019Q2: Δ-26 · h=132 2019Q3: Δ-4 · h=128 2019Q4: Δ-3 · h=125 2020Q1: Δ-3 · h=122 2020Q2: Δ+15 · h=137 2020Q3: Δ+2 · h=139 2020Q4: Δ+8 · h=147 2021Q1: Δ+28 · h=175 2021Q2: Δ-22 · h=153 2021Q3: Δ+3 · h=156 2021Q4: Δ+2 · h=158 2022Q1: Δ-14 · h=144 2022Q2: Δ-11 · h=133 2022Q3: Δ+4 · h=137 2022Q4: Δ+1 · h=138 2023Q1: Δ+0 · h=138 2023Q2: Δ-6 · h=132 2023Q3: Δ-3 · h=129 2023Q4: Δ+14 · h=143 2024Q1: Δ+21 · h=164 2024Q2: Δ-17 · h=147 2024Q3: Δ-22 · h=125 2024Q4: Δ+5 · h=130 2025Q1: Δ-1 · h=129 2025Q2: Δ-15 · h=114 2025Q3: Δ-9 · h=105 2025Q4: Δ-17 · h=88 2026Q1: Δ+20 · h=108 2018Q1: holders=133 2018Q2: holders=126 2018Q3: holders=131 2018Q4: holders=134 2019Q1: holders=158 2019Q2: holders=132 2019Q3: holders=128 2019Q4: holders=125 2020Q1: holders=122 2020Q2: holders=137 2020Q3: holders=139 2020Q4: holders=147 2021Q1: holders=175 2021Q2: holders=153 2021Q3: holders=156 2021Q4: holders=158 2022Q1: holders=144 2022Q2: holders=133 2022Q3: holders=137 2022Q4: holders=138 2023Q1: holders=138 2023Q2: holders=132 2023Q3: holders=129 2023Q4: holders=143 2024Q1: holders=164 2024Q2: holders=147 2024Q3: holders=125 2024Q4: holders=130 2025Q1: holders=129 2025Q2: holders=114 2025Q3: holders=105 2025Q4: holders=88 2026Q1: holders=108 -28 -14 +0 +14 +28 79132184 18Q119Q120Q121Q122Q123Q124Q125Q126Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 5 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 16%
2024Q1 Top 14% -18.7% -18.2%
2021Q1 Top 12% -24.1% -34.0%
2019Q1 Top 12% -19.5% -55.2%
2018Q1 Top 16% -4.9% -22.2%

Options Sentiment

Put holders
2
QoQ: +1
Call holders
3
QoQ: +2

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-1.11
EPS YoY
Revenue (TTM)
$0.2B
Revenue YoY
+2.0%
Quarterly Revenue & EPS (4Y)
2022-06-30: $26M 2022-09-30: $42M 2022-12-31: $73M 2023-03-31: $24M 2023-06-30: $13M 2023-09-30: $10M 2023-12-31: $11M 2024-03-31: $9M 2024-06-30: $11M 2024-09-30: $111M 2024-12-31: $19M 2025-03-31: $13M 2025-06-30: $22M 2025-09-30: $73M 2025-12-31: $41M 2026-03-31: $21M 2022-06-30: EPS -0.67 2022-09-30: EPS -0.40 2022-12-31: EPS 0.20 2023-03-31: EPS -0.61 2023-06-30: EPS 0.92 2023-09-30: EPS 0.28 2023-12-31: EPS -0.74 2024-03-31: EPS -0.84 2024-06-30: EPS -0.89 2024-09-30: EPS 0.90 2024-12-31: EPS -0.24 2025-03-31: EPS -0.65 2025-06-30: EPS -0.57 2025-09-30: EPS 0.27 2025-12-31: EPS -0.23 2026-03-31: EPS -0.58 0M 55M 111M $M -0.98 0.02 1.01 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 48 2023-06-30: PE 47.52023-09-30: PE 9 8 29 50 20222023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)